121 related articles for article (PubMed ID: 20367524)
1. Desensitization of patients with allergic reactions to immunosuppressives in the treatment of inflammatory bowel disease.
Korelitz BI; Reddy B; Bratcher J
Expert Opin Drug Saf; 2010 May; 9(3):379-82. PubMed ID: 20367524
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
4. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
5. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
[TBL] [Abstract][Full Text] [Related]
6. Pancreatitis in inflammatory bowel diseases.
Pitchumoni CS; Rubin A; Das K
J Clin Gastroenterol; 2010 Apr; 44(4):246-53. PubMed ID: 20087199
[TBL] [Abstract][Full Text] [Related]
7. General principles of medical therapy of inflammatory bowel disease.
Friedman S
Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
[TBL] [Abstract][Full Text] [Related]
8. Azathioprine in inflammatory bowel disease, a safe alternative?
Tanis AA
Mediators Inflamm; 1998; 7(3):141-4. PubMed ID: 9705598
[TBL] [Abstract][Full Text] [Related]
9. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
10. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
11. Review article: monitoring of immunomodulators in inflammatory bowel disease.
Aberra FN; Lichtenstein GR
Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
[TBL] [Abstract][Full Text] [Related]
12. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease.
Ananthakrishnan AN; Attila T; Otterson MF; Lipchik RJ; Massey BT; Komorowski RA; Binion DG
J Clin Gastroenterol; 2007 Aug; 41(7):682-8. PubMed ID: 17667053
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine and mercaptopurine: lymphoma.
Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
[TBL] [Abstract][Full Text] [Related]
14. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.
Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH
Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Aranda R; Horgan K
Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
[TBL] [Abstract][Full Text] [Related]
16. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
Rogler G
Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
[No Abstract] [Full Text] [Related]
17. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
Wahed M; Louis-Auguste JR; Baxter LM; Limdi JK; McCartney SA; Lindsay JO; Bloom SL
Aliment Pharmacol Ther; 2009 Sep; 30(6):614-20. PubMed ID: 19552632
[TBL] [Abstract][Full Text] [Related]
18. Optimizing therapy for inflammatory bowel disease.
Robinson M
Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease.
Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA
Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):563-7. PubMed ID: 15317038
[TBL] [Abstract][Full Text] [Related]
20. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH
Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]